Accepting Vaccinated Patients Only

MD 2.0 doctors, Dr. Lubarsky and Dr. Poncy provide the best concierge medical care in South Florida.

PRIMARY CARE

At MD 2.0, we provide patients with superior primary care. We want to be the first to know about any health concerns that may arise. Primary care is performed and managed by your personal physician, Dr. Poncy or Dr. Lubarsky who are available to you 24/7.

PREVENTATIVE HEALTH

Drs. Lubarsky and Poncy believe in more than just treating you when you are sick. Our preventative medicine doctors want to ensure you are healthy year round by promoting a healthy lifestyle, yearly executive level physical exams, and helping to prevent disease.

INTERNAL MEDICINE

At MD 2.0, our concierge physician practice focuses on providing high quality care and individualized attention to each patient. Our model allows us to spend more time with each patient, allowing us to work closely with you on prevention, diagnosis, and treatment of diseases and complex illnesses.

Personalized Primary Care

At our Concierge Family Practice, MD 2.0, our concierge medical doctors provide personalized, patient-centered care, and make it our primary goal. Here are just a few benefits of partnering with MD 2.0 in Jupiter for your primary healthcare needs:

  • Personalized and attentive care, for each and every patient
  • 24/7 access to our highly regarded, internal medicine physicians
  • Same-day appointments with shorter wait times and longer visits
  • A focus on total care of the patient, body, mind, and spirit
  • Prevention and optimal management of chronic conditions
  • Lifestyle, nutritional support, and anti-aging solutions
  • Unhurried, personable, and uninterrupted appointments

Meet Our Doctors

Conceirge-Medicine-Dr.-Amir-Lubarsky

Dr. Amir Lubarsky

Board Certified Internist in Jupiter, FL

Dr. Amir Lubarsky's love of medicine allows him to listen compassionately and intently to his patients in order to provide the best outcomes.
jupiter concierge medicine Morgan poncy

Dr. Morgan Poncy

Board Certified Internal Medicine Doctor in Jupiter, FL

Dr. Morgan Poncy is a board certified internist who was raised in the Jupiter area.

500

HAPPY PATIENTS

35

FRIENDLY STAFF

365

DAYS AVAILABLE

10

SPECIALITIES

LATEST NEWS

Understanding How Heat Affects Your Medications

As the summer heat intensifies, it's crucial to know how extreme temperatures can impact your medications. For patients of our primary care concierge doctor's office, staying informed about these effects can help prevent adverse health outcomes and ensure the efficacy of your treatments. Our primary care doctors in Jupiter have the information you need to know about managing your medications during a heatwave:

Medicines Susceptible to Heat Damage

Certain medications are particularly vulnerable to high temperatures, which can alter their effectiveness and safety:

  1. Blood Pressure Medications: Diuretics reduce fluid in the blood, increasing the risk of dehydration. Beta-blockers can decrease blood flow to the skin, reducing your ability to sense heat.
  2. Antidepressants: Some antidepressants can impair the body's ability to cool itself, exacerbating the risk of heat-related illnesses.
  3. Pain Relievers: Medications like aspirin can deplete fluid and sodium levels, heightening the risk of dehydration.
  4. Antibiotics and Acne Treatments: These can increase sensitivity to the sun, leading to rashes or severe sunburns. Using sun-protective clothing and high-SPF sunscreen is advisable.

Combining these medications with heat exposure can lead to dizziness, lightheadedness, and falls. Alcohol can amplify these effects, so it's best to limit its consumption during hot weather.

Proper Storage of Medications

Unless otherwise specified, medications generally need to be stored in cool, dry places. Here are some tips for managing your medicines during travel or extreme heat:

  • Traveling by Car: Keep medications in a cooler with ice packs to maintain a safe temperature.
  • Flying: Carry medications in your carry-on bag, as the cargo hold can reach freezing temperatures.
  • Home Storage: Avoid storing medications in hot areas like cars or near windows.

Concerns with Mail-Order Prescriptions

Mail-order prescriptions are convenient but can be vulnerable to temperature extremes during transit. Here’s how to ensure their safety:

  • Storage and Shipping: Pharmacies should ship heat-sensitive medications with ice packs and temperature monitors.
  • Upon Delivery: If you suspect your medication was exposed to excessive heat, contact your pharmacy immediately to discuss replacement options.

Research and Recommendations

The interaction between heat and medications is an evolving area of study. Some common concerns may lack extensive scientific backing, but it's crucial to err on the side of caution:

  • Behavioral Adjustments: Stay out of direct sunlight and remain hydrated. These practices can help mitigate the heat’s impact on your medications.
  • Consult Your Doctor: Discuss any concerns about your medications and heat exposure with your healthcare provider.

Dr. Renee Salas of Massachusetts General Hospital emphasizes the growing need to identify medications most at risk as climate change progresses. Staying informed and proactive about your medication management can help you stay healthy during extreme heat conditions.

If you have questions about your medications and how to protect them from heat, please contact our office or consult your pharmacist. Your health and safety are our top priorities.

For more information, visit our website or follow us on Facebook for regular updates and tips on staying healthy this summer.

New Hope in Alzheimer’s Treatment: FDA Approves Eli Lilly’s Kisunla

Alzheimer's disease remains one of the most challenging conditions faced by the medical community, with millions of Americans affected and numbers projected to rise sharply in the coming decades. However, recent developments have brought new hope to those battling this devastating disease. The FDA’s approval of Eli Lilly’s Kisunla, a monoclonal antibody infusion, marks a significant step forward in the treatment of mild to early cases of dementia caused by Alzheimer’s.

Understanding Kisunla: A Breakthrough in Alzheimer's Treatment

Kisunla, also known as donanemab, is designed to slow cognitive decline in patients with early-stage Alzheimer’s. In a clinical trial involving 1,700 participants, patients receiving monthly IV infusions of donanemab experienced a 35% slower decline in cognitive abilities compared to those on a placebo. This improvement, though modest, provides a crucial window of opportunity for patients and their families to enjoy a better quality of life and more time together.

What This Means for Patients at MD2.0 in Jupiter, Florida

As a concierge primary care provider, MD2.0 in Jupiter, Florida, is committed to offering the latest and most effective treatments to our patients. The approval of Kisunla is particularly significant for our practice, where personalized care and cutting-edge medical advancements go hand in hand.

Dr. Suzanne Schindler, a neurologist at Washington University in St. Louis, emphasized the importance of having multiple treatment options available for Alzheimer’s patients. “I’m thrilled to have different options to help my patients,” she said. This sentiment resonates deeply with us at MD2.0, where we strive to provide the best possible outcomes for our patients.

Balancing Benefits and Risks

While Kisunla offers hope, it’s essential to weigh its benefits against potential downsides. The treatment involves regular IV infusions and carries risks such as brain swelling. Additionally, the cost of a year’s therapy with Kisunla is estimated at $32,000, higher than the $26,500 annual cost of Leqembi, another recently approved Alzheimer’s drug.

At MD2.0, we work closely with our patients to ensure they are fully informed about their treatment options. We believe in a collaborative approach, where patients and their families participate in making decisions that best suit their health and financial circumstances.

The Road Ahead

With an estimated 6.7 million Americans currently living with Alzheimer’s, and projections indicating this number could double by 2060, the need for effective treatments has never been greater. The approval of Kisunla is a promising development, offering a new ray of hope for those affected by this relentless disease.

As we continue to monitor advancements in Alzheimer's research, MD2.0 remains dedicated to integrating the latest treatments into our practice. Our goal is to provide comprehensive, compassionate care tailored to each patient's unique needs.

Conclusion

The FDA's approval of Eli Lilly’s Kisunla represents a significant milestone in the fight against Alzheimer’s disease. For patients at MD2.0 in Jupiter, Florida, this new treatment offers a promising option for slowing the progression of cognitive decline. As always, we are here to guide our patients through every step of their healthcare journey, ensuring they receive the best possible care.

Stay informed about the latest Alzheimer’s treatment by following our blog and connecting with us on Facebook. Together, we can navigate the challenges of Alzheimer’s disease and work towards a brighter future.

Get Started Today With Personalized Medical Care

The best concierge medical care in South Florida. Contact us today!